Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

VALR launches Africa's first centralized exchange perpetuals on Hyperliquid's decentralized Layer-1 blockchain.

Market News
03 Jul 2026
Crypto Briefing
View Source
Bullish
pluang ai news

VALR, Africa's largest crypto exchange, has integrated Hyperliquid's Layer-1 blockchain to offer a new perpetuals product with over 200 markets, including equities, commodities, forex, and crypto. This marks the first time a major regulated centralized exchange has built directly on a decentralized protocol, blending centralized regulation with decentralized liquidity and trade execution. The product aims to provide deep on-chain liquidity and high-speed trading, with web access launching July 6 and mobile support soon after. This move validates Hyperliquid's protocol and signals a new hybrid model for crypto trading infrastructure.

More News

AI in Pathology market to nearly double by 2035 despite US-Israel-Iran conflict disruptions

AI in Pathology market to nearly double by 2035 despite US-Israel-Iran conflict disruptions

The global AI in Pathology market, valued at $28.75 million in 2025, is projected to grow at a 9.12% CAGR to reach $68.81 million by 2035. Growth is driven by rising demand for digital pathology, AI diagnostics, and improved workflow efficiency throu...

Market News
Neutral
31 minutes ago
AI data centers drive major infrastructure shifts with hyperscalers and sovereign initiatives leading growth.

AI data centers drive major infrastructure shifts with hyperscalers and sovereign initiatives leading growth.

The global AI data center market is rapidly expanding due to the rise of generative AI and advanced cognitive analytics, requiring purpose-built, high-density facilities with advanced cooling and networking technologies. Hyperscalers like Microsoft, ...

Market News
Bullish
32 minutes ago
SKYRIZI sales hit $11.7B in 2024 with 51% growth, expanding across multiple disease indications.

SKYRIZI sales hit $11.7B in 2024 with 51% growth, expanding across multiple disease indications.

SKYRIZI achieved blockbuster sales of $11.7 billion in 2024, growing 51% year-over-year, driven by approvals in psoriasis, psoriatic arthritis, and inflammatory bowel diseases like Crohn's. Its strong clinical efficacy targeting the IL-23 pathway and...

Market News
Bullish
33 minutes ago
Photodynamic therapy market to grow at 8.3% CAGR, reaching $1.53B by 2035 driven by cancer and dermatology uses.

Photodynamic therapy market to grow at 8.3% CAGR, reaching $1.53B by 2035 driven by cancer and dermatology uses.

The global photodynamic therapy (PDT) market is forecasted to grow from $749 million in 2023 to $1.53 billion by 2035, at a CAGR of 8.3%. Growth is fueled by PDT's minimally invasive nature and expanding applications in oncology, dermatology, and ant...

Market News
Bullish
35 minutes ago
Cancer metabolism therapeutics market to grow to $26.3B by 2035, driven by precision medicine and rising cancer cases.

Cancer metabolism therapeutics market to grow to $26.3B by 2035, driven by precision medicine and rising cancer cases.

The cancer metabolism-based therapeutics market is projected to grow from $3.7 billion in 2026 to $26.3 billion by 2035, with a CAGR of 24.3%. This growth is fueled by advances in precision medicine targeting unique cancer cell metabolic pathways, in...

Market News
Bullish
36 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App